Harold A. Sackeim mainly investigates Electroconvulsive therapy, Psychiatry, Depression, Anesthesia and Major depressive disorder. Harold A. Sackeim interconnects Magnetic seizure therapy, Seizure threshold, Cognition, Antidepressant and Prospective cohort study in the investigation of issues within Electroconvulsive therapy. His studies deal with areas such as Internal medicine, Randomized controlled trial and Clinical trial as well as Psychiatry.
His work deals with themes such as Pharmacotherapy and Pediatrics, which intersect with Depression. The various areas that Harold A. Sackeim examines in his Major depressive disorder study include Intention-to-treat analysis, Mood disorders, Randomization, Number needed to treat and Generalized seizure. His work focuses on many connections between Treatment-resistant depression and other disciplines, such as Bipolar disorder, that overlap with his field of interest in Vagus nerve stimulation.
Harold A. Sackeim mostly deals with Electroconvulsive therapy, Psychiatry, Depression, Internal medicine and Anesthesia. His studies in Electroconvulsive therapy integrate themes in fields like Magnetic seizure therapy, Seizure threshold, Stimulus, Cognition and Antidepressant. Harold A. Sackeim has researched Psychiatry in several fields, including Randomized controlled trial, Pediatrics, Clinical psychology and Clinical trial.
The concepts of his Depression study are interwoven with issues in Transcranial magnetic stimulation, Pharmacotherapy and Vagus nerve stimulation. The study incorporates disciplines such as Endocrinology, Psychosis, Schizophrenia and Cardiology in addition to Internal medicine. His Anesthesia study incorporates themes from Bipolar disorder and Electroencephalography.
Electroconvulsive therapy, Psychiatry, Randomized controlled trial, Transcranial magnetic stimulation and Internal medicine are his primary areas of study. His Electroconvulsive therapy research incorporates elements of Anesthesia, Hamilton Rating Scale for Depression, Bipolar disorder, Cognition and Amnesia. Harold A. Sackeim regularly ties together related areas like Adverse effect in his Psychiatry studies.
His Randomized controlled trial research is multidisciplinary, incorporating elements of Antidepressant and Depression. Treatment-resistant depression is the focus of his Depression research. His Transcranial magnetic stimulation study combines topics from a wide range of disciplines, such as Major depressive disorder, Prefrontal cortex and Physical medicine and rehabilitation.
His primary areas of study are Psychiatry, Randomized controlled trial, Electroconvulsive therapy, Internal medicine and Transcranial magnetic stimulation. His work in Antidepressant and Treatment-resistant depression is related to Psychiatry. The Electroconvulsive therapy study combines topics in areas such as Anesthesia, Venlafaxine, Cognition, Amnesia and Prospective cohort study.
In his study, which falls under the umbrella issue of Anesthesia, Bipolar disorder is strongly linked to Hamilton Rating Scale for Depression. His Transcranial magnetic stimulation study combines topics in areas such as Major depressive disorder, Depression, Physical therapy and Young adult. Harold A. Sackeim combines subjects such as Prefrontal cortex and Anxiety with his study of Depression.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Acute and Longer- Term Outcomes in Depressed Outpatients Requiring One or Several Treatment Steps: A STAR*D Report
A. John Rush;Madhukar H. Trivedi;Stephen R. Wisniewski;Andrew A. Nierenberg.
American Journal of Psychiatry (2006)
Efficacy and safety of transcranial magnetic stimulation in the acute treatment of major depression: A multisite randomized controlled trial.
John P. O’Reardon;H. Brent Solvason;Philip G. Janicak;Shirlene Sampson.
Biological Psychiatry (2007)
Effects of stimulus intensity and electrode placement on the efficacy and cognitive effects of electroconvulsive therapy
Harold A. Sackeim;Joan Prudic;D.P. Devanand;Judith E. Kiersky.
The New England Journal of Medicine (1993)
Sequenced treatment alternatives to relieve depression (STAR * D): rationale and design
A.John Rush;Maurizio Fava;Stephen R Wisniewski;Philip W Lavori.
Controlled Clinical Trials (2004)
The definition and meaning of treatment-resistant depression.
Harold A. Sackeim.
The Journal of Clinical Psychiatry (2001)
Daily left prefrontal transcranial magnetic stimulation therapy for major depressive disorder: a sham-controlled randomized trial
Mark S. George;Sarah H. Lisanby;David Avery;William M. McDonald.
Archives of General Psychiatry (2010)
A prospective, randomized, double-blind comparison of bilateral and right unilateral electroconvulsive therapy at different stimulus intensities.
Harold A. Sackeim;Joan Prudic;D. P. Devanand;Mitchell S. Nobler.
Archives of General Psychiatry (2000)
Hemispheric Asymmetry in the Expression of Positive and Negative Emotions: Neurologic Evidence
Harold A. Sackeim;Mark S. Greenberg;Andrew L. Weiman;Ruben C. Gur.
JAMA Neurology (1982)
Vagus nerve stimulation (VNS) for treatment-resistant depressions: a multicenter study.
A. John Rush;Mark S. George;Mark S. George;Harold A. Sackeim;Lauren B. Marangell.
Biological Psychiatry (2000)
Continuation pharmacotherapy in the prevention of relapse following electroconvulsive therapy: a randomized controlled trial.
Harold A. Sackeim;Roger F. Haskett;Benoit H. Mulsant;Michael E. Thase.
Profile was last updated on December 6th, 2021.
Research.com Ranking is based on data retrieved from the Microsoft Academic Graph (MAG).
The ranking d-index is inferred from publications deemed to belong to the considered discipline.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: